Dr. Antonio Privitera

Chronic Anal Fistula: Long-Term Management

Flowchart showing long-term management strategies for chronic anal fistula including seton placement, medical therapy, and surgical options
Flowchart showing long-term management strategies for chronic anal fistula including seton placement, medical therapy, and surgical options

Most simple anal fistulas are cured with one operation. But some fistulas – particularly complex ones, Crohn’s-related ones, or those that have failed multiple surgical attempts – require long-term management strategies rather than a single curative procedure. For full treatment approach, see anal fistula treatment in Dubai. This is not failure. It is an honest approach to a difficult condition.

When Is Long-Term Management Relevant?

  • Crohn’s fistula that has not responded to surgery and medical treatment
  • Very complex fistula involving most of the sphincter where cure is too risky for continence
  • Multiple failed previous operations the anatomy is distorted and further surgery carries high risk
  • Patient with poor sphincter function where any further division would cause incontinence
  • Older patient who prefers quality of life over repeated surgery

Strategy 1: Long-Term Draining Seton

A loose draining seton in Dubai keeps the fistula tract open permanently. This prevents recurrent abscess formation (the cycle of filling and painful swelling) while allowing ongoing drainage that the patient can manage.

  • The seton must be maintained – replaced periodically
  • Patients adapt well – most say the seton is much preferable to recurrent abscesses
  • Suitable for: Crohn’s fistulas, complex fistulas where cure attempts have failed, patients who decline further curative surgery
Diagram showing long-term draining seton in anal fistula maintaining continuous drainage and preventing abscess recurrence
A long-term seton keeps the tract open, preventing painful abscess formation and controlling symptoms.

Strategy 2: Medical Treatment (Crohn’s Fistulas)

For Crohn’s-related fistulas, medical treatment plays a central role:

Biologics

  • Infliximab (Remicade) – anti-TNF antibody: Best evidence for inducing fistula closure in Crohn’s. Closure rates of 30-55% with maintained dosing.
  • Adalimumab (Humira): Alternative anti-TNF with similar efficacy
  • Ustekinumab, vedolizumab: For patients who fail anti-TNF therapy

Antibiotics

  • Metronidazole, ciprofloxacin: Can suppress discharge and control secondary infection but do not close fistulas

Important: Medical treatment in Crohn’s fistulas should be coordinated between the colorectal surgeon and the gastroenterologist.

Infographic showing medical treatment of Crohn’s-related anal fistula including biologics and antibiotics
Medical therapy plays a central role in Crohn’s fistulas, often combined with surgical management.

Strategy 3: Stoma (in Selected Cases)

A temporary or permanent defunctioning stoma (colostomy or ileostomy) diverts the fecal stream away from the anorectal area, reducing contamination and sometimes allowing a very complex fistula to heal or settle. Used when:

  • Extensive Crohn’s perianal disease that cannot be controlled by other means
  • Fistula associated with anorectal stricture or destroyed perineum
  • Patient refuses seton but has recurrent sepsis
Medical illustration showing stoma diverting fecal flow away from anorectal area to reduce fistula contamination
A stoma diverts stool away from the affected area, helping control severe or complex fistula disease.

Quality of Life With Chronic Fistula

Living with a chronic fistula even a managed one affects quality of life:

  • Discharge and soiling require pads socially restrictive
  • Odor is a concern for many patients
  • Pain during flare-ups
  • Impact on sexual activity and relationships

These are legitimate concerns and should be discussed openly with your surgeon. There are practical strategies to improve quality of life at each stage:

  • Barrier creams (zinc oxide) to protect perianal skin from constant moisture
  • Appropriate absorbent pads
  • Prompt treatment of any abscess flare-up to prevent a small collection becoming a large one
  • Regular follow-up – fistulas that have been ‘stable’ can become complex over time

📱 WhatsApp: +971 55 318 8469

📞 Phone: +971 55 318 8469

AUTHOR AUTHORITY BLOCK
All content on this page is written and reviewed by Prof. Dr. Antonio Privitera, consultant colorectal surgeon, with fellowship training at the Mayo Clinic (USA) and the Royal College of Surgeons (UK), and European Board Certification in Colorectal Surgery. Dr. Privitera practises across Dubai and Abu Dhabi and specialises in the full range of anorectal conditions including hemorrhoids, anal fissure, anal fistula, and colorectal cancer.

About the Author

Professor Dr Antonio Privitera
Consultant Colorectal & General Surgeon | Proctologist
FRCS (England)
FASCRS
MD
PhD
70+ Publications
Mayo Clinic Fellowship

Dr. Privitera is the only surgeon in the world with both a Mayo Clinic (Rochester, USA) and University of London Colorectal Surgery Fellowship. He completed an advanced laparoscopic and robotic fellowship in Seoul, South Korea.

He previously served as Lead Colorectal Surgeon at Tawam Hospital–Johns Hopkins Abu Dhabi and Associate Professor at UAE University.

He is a Fellow of the American Society of Colon and Rectal Surgery (FASCRS), Fellow of the Royal College of Surgeons of England (FRCS), and author of over 70 peer-reviewed publications. He also served as General Secretary of the Emirates Society of Colon and Rectal Surgery (2021–2024).

He practices across Dubai and Abu Dhabi.

Leave a Comment

Your email address will not be published. Required fields are marked *